Can inhaled steroids help newborns breathe easier after meconium aspiration?
NCT ID NCT07763119
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether giving an inhaled steroid (budesonide) to newborns with meconium aspiration syndrome can speed up their recovery. Meconium aspiration happens when a baby breathes in a mixture of meconium and amniotic fluid during birth, causing lung inflammation and breathing trouble. The study will compare babies receiving the steroid plus standard care against those receiving a placebo (saline) plus standard care, measuring how quickly they recover, need for oxygen or a breathing machine, and length of hospital stay.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nebulised budesonide (an inhaled corticosteroid) given alongside standard care
- What this could lead to
- If effective, this could offer a simple, targeted way to reduce lung inflammation in newborns with meconium aspiration, potentially shortening hospital stays and improving recovery.
- What could go wrong
- This is a small, single-center trial, and results may not apply broadly. The steroid may not improve outcomes over standard care, and potential risks include local irritation or systemic effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MECONIUM ASPIRATION SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Khyber Teaching Hospital Peshawar
Peshawar, Khyber Pakhtunkhwa, 25000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.